Fibulin-3 has also been shown to suppress growth signaling in nasopharyngeal carcinomas and glioma [62, 63], and can inhibit cell migration and MMP-induced cancer cell invasion in other cancers [58, 62, 64]. Here, EFEMP1 is linked to central nervous system cancer.